InvestorsHub Logo
Followers 50
Posts 9086
Boards Moderated 1
Alias Born 01/13/2007

Re: Tasso9 post# 5434

Friday, 11/10/2017 7:03:43 AM

Friday, November 10, 2017 7:03:43 AM

Post# of 21544
Apparently an asthma drug they are hoping could be beneficial. Seems comparable to some other MOAs that deal with inflammation maybe, but certainly not any type of major disease improvement expected best I can tell. They are running a double blinded, placebo controlled trial however, even if its only 2a. Good luck to them.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SNPX News